YOUR BUSINESS AUTHORITY

Springfield, MO

Home
Digital Edition
Events
Industries
Opinion
Podcasts
Photo Galleries
News Features
Sponsored Content

Log in Subscribe

Bristol Myers inks $286M acquisition

Posted online March 11, 2025 | 7:42 am

Bristol Myers Squibb agreed to buy cancer cell therapy maker 2seventy bio.

The all-cash deal is worth roughly $286 million.

The companies have partnered on a treatment for multiple myeloma, a type of blood cancer.

Read more from Reuters.

Comments

No comments on this story |

Please log in to add your comment

More from SBJ Daily Update

Judge denies Overhue's ask for preliminary injunction against city's data center moratorium

Editors' Pick

CASA plans to launch clubhouse in Taney County

Nonprofit receives $250K grant to help fund facility.

Most Read

Missouri gains 131 new Opportunity Zones

Three incumbents plan to run for SPS board in April

Pregnancy Care Center appoints new CEO

Tesla to wind down Cybertruck production

Monday Morning Business Leads: Nov. 9, 2026

The Digital Edition from SBJ

Ascension cutting 51 jobs, closing St. Louis County operation

SBJ.net Poll

Overall, were you satisfied with the Nov. 3 election results?

*

Update cookies preferences